Fimbrial Profiles Predict Virulence of Uropathogenic Escherichia coli Strains: Contribution of Ygi and Yad Fimbriae

ABSTRACT Escherichia coli, a cause of ∼90% of urinary tract infections (UTI), utilizes fimbrial adhesins to colonize the uroepithelium. Pyelonephritis isolate E. coli CFT073 carries 12 fimbrial operons, 5 of which have never been studied. Using multiplex PCR, the prevalence of these 12 and 3 additional fimbrial types was determined for a collection of 303 E. coli isolates (57 human commensal, 32 animal commensal, 54 asymptomatic bacteriuria, 45 complicated UTI, 38 uncomplicated cystitis, and 77 pyelonephritis). The number of fimbrial types per E. coli isolate was distributed bimodally: those with low (3.2 ± 1.1) and those with high (8.3 ± 1.3) numbers of fimbrial types (means ± standard errors of the means). The fimbrial genes ygiL, yadN, yfcV, and c2395 were significantly more prevalent among urine isolates than human commensal isolates. The effect of deletion of Ygi and Yad fimbrial operons on growth, motility, biofilm formation, adherence to immortalized human epithelial cells, and pathogenesis in the mouse model of UTI was examined. Yad fimbriae were necessary for wild-type levels of adherence to a bladder epithelial cell line and for biofilm formation. Deletion of these fimbrial genes increased motility. Ygi fimbriae were necessary for wild-type levels of adherence to a human embryonic kidney cell line, biofilm formation, and in vivo fitness in the urine and kidneys. Complementation of each fimbrial mutant restored wild-type levels of motility, biofilm formation, adherence and, for ygi, in vivo fitness. A double deletion strain, Δygi Δyad, was attenuated in the urine, bladder, and kidneys in the mouse model, demonstrating that these fimbriae contribute to uropathogenesis.

[1]  M. Nei,et al.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. , 2011, Molecular biology and evolution.

[2]  Andrew P. Hodges,et al.  Presence of Putative Repeat-in-Toxin Gene tosA in Escherichia coli Predicts Successful Colonization of the Urinary Tract , 2011, mBio.

[3]  Bertrand Picard,et al.  Animal and human pathogenic Escherichia coli strains share common genetic backgrounds. , 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[4]  B. Molitoris,et al.  Uropathogenic Escherichia coli P and Type 1 Fimbriae Act in Synergy in a Living Host to Facilitate Renal Colonization Leading to Nephron Obstruction , 2011, PLoS pathogens.

[5]  D. Rasko,et al.  Escherichia coli Global Gene Expression in Urine from Women with Urinary Tract Infection , 2010, PLoS pathogens.

[6]  R. M. Vejborg,et al.  Functional genomics of probiotic Escherichia coli Nissle 1917 and 83972, and UPEC strain CFT073: comparison of transcriptomes, growth and biofilm formation , 2010, Molecular Genetics and Genomics.

[7]  H. Mobley,et al.  Host–pathogen interactions in urinary tract infection , 2010, Nature Reviews Urology.

[8]  Olivier Tenaillon,et al.  The population genetics of commensal Escherichia coli , 2010, Nature Reviews Microbiology.

[9]  L. Wieler,et al.  Adhesive threads of extraintestinal pathogenic Escherichia coli , 2009, Gut pathogens.

[10]  J. Hacker,et al.  The SfaXII protein from newborn meningitis E. coli is involved in regulation of motility and type 1 fimbriae expression. , 2009, Microbial pathogenesis.

[11]  K. Jarrell.  Pili and flagella : current research and future trends , 2009 .

[12]  H. Mobley,et al.  PapX, a P Fimbrial Operon-Encoded Inhibitor of Motility in Uropathogenic Escherichia coli , 2008, Infection and Immunity.

[13]  G. Waksman,et al.  Architectures and biogenesis of non-flagellar protein appendages in Gram-negative bacteria , 2008, The EMBO journal.

[14]  H. Mobley,et al.  Multiple Genes Repress Motility in Uropathogenic Escherichia coli Constitutively Expressing Type 1 Fimbriae , 2008, Journal of bacteriology.

[15]  Harry L. T. Mobley,et al.  Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract , 2007, Proceedings of the National Academy of Sciences.

[16]  Sarah C. Goslee,et al.  The ecodist Package for Dissimilarity-based Analysis of Ecological Data , 2007 .

[17]  Anne-Béatrice Dufour,et al.  The ade4 Package: Implementing the Duality Diagram for Ecologists , 2007 .

[18]  H. Mobley,et al.  Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney. , 2007, Kidney international.

[19]  G. Ulett,et al.  The role of F9 fimbriae of uropathogenic Escherichia coli in biofilm formation. , 2007, Microbiology.

[20]  H. Mobley,et al.  Complex Interplay between Type 1 Fimbrial Expression and Flagellum-Mediated Motility of Uropathogenic Escherichia coli , 2007, Journal of bacteriology.

[21]  E. Denamur,et al.  Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source. , 2006, The Journal of infectious diseases.

[22]  B. Foxman,et al.  Molecular Epidemiologic Identification of Escherichia coli Genes That Are Potentially Involved in Movement of the Organism from the Intestinal Tract to the Vagina and Bladder , 2006, Journal of Clinical Microbiology.

[23]  R. Welch,et al.  Regulation of Type 1 Fimbriae by Unlinked FimB- and FimE-Like Recombinases in Uropathogenic Escherichia coli Strain CFT073 , 2006, Infection and Immunity.

[24]  M. Kuskowski,et al.  Bacterial Characteristics in Relation to Clinical Source of Escherichia coli Isolates from Women with Acute Cystitis or Pyelonephritis and Uninfected Women , 2005, Journal of Clinical Microbiology.

[25]  H. Mobley,et al.  Role of Motility in the Colonization of Uropathogenic Escherichia coli in the Urinary Tract , 2005, Infection and Immunity.

[26]  H. Mobley,et al.  Coordinate Expression of Fimbriae in Uropathogenic Escherichia coli , 2005, Infection and Immunity.

[27]  J. R. Johnson,et al.  Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. , 2005, The Journal of infectious diseases.

[28]  Javier Garaizar,et al.  In silico analysis of complete bacterial genomes: PCR, AFLP-PCR and endonuclease restriction , 2004, Bioinform..

[29]  Harry L. T. Mobley,et al.  Pathogenic Escherichia coli , 2004, Nature Reviews Microbiology.

[30]  M. Schmidt,et al.  The Pix pilus adhesin of the uropathogenic Escherichia coli strain X2194 (O2 : K(-): H6) is related to Pap pili but exhibits a truncated regulatory region. , 2003, Microbiology.

[31]  F. Blattner,et al.  Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  W. Donovan,et al.  Role of Type 1 Fimbria- and P Fimbria-Specific Adherence in Colonization of the Neurogenic Human Bladder by Escherichia coli , 2002, Infection and Immunity.

[33]  Betsy Foxman,et al.  Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. , 2002, The American journal of medicine.

[34]  H. Akaza,et al.  Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cells. , 2002, FEMS immunology and medical microbiology.

[35]  M. Schembri,et al.  Biofilm Formation in a Hydrodynamic Environment by Novel FimH Variants and Ramifications for Virulence , 2001, Infection and Immunity.

[36]  D. Scholes,et al.  A prospective study of asymptomatic bacteriuria in sexually active young women. , 2000, The New England journal of medicine.

[37]  B. Wanner,et al.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  S. Hultgren,et al.  Assembly of complex organelles: pilus biogenesis in gram-negative bacteria as a model system. , 2000, Methods.

[39]  H. Mobley,et al.  In vivo phase variation of Escherichia coli type 1 fimbrial genes in women with urinary tract infection. , 1999, Infection and immunity.

[40]  R. Kolter,et al.  Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili , 1998, Molecular microbiology.

[41]  R. Selvarangan,et al.  Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line. , 1997, The Journal of infectious diseases.

[42]  L. Truong,et al.  Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. , 1997, The Journal of clinical investigation.

[43]  C. Svanborg,et al.  Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. R. Johnson,et al.  A novel multiply primed polymerase chain reaction assay for identification of variant papG genes encoding the Gal(alpha 1-4)Gal-binding PapG adhesins of Escherichia coli. , 1996, The Journal of infectious diseases.

[45]  J. Hacker,et al.  S fimbriae of uropathogenic Escherichia coli bind to primary human renal proximal tubular epithelial cells but do not induce expression of intercellular adhesion molecule 1 , 1995, Infection and immunity.

[46]  S. Moseley,et al.  Urovirulence determinants in Escherichia coli isolates causing first-episode and recurrent cystitis in women. , 1991, The Journal of infectious diseases.

[47]  J. R. Johnson,et al.  Virulence factors in Escherichia coli urinary tract infection , 1991, Clinical Microbiology Reviews.

[48]  H. Mobley,et al.  Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains , 1990, Infection and immunity.

[49]  M. Hellström,et al.  Secretor state and renal scarring in girls with recurrent pyelonephritis. , 1989, FEMS microbiology immunology.

[50]  H. Mobley,et al.  Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients. , 1987, The Journal of urology.

[51]  E. Balish,et al.  In vitro and in vivo adherence of uropathogenic Escherichia coli strains. , 1986, The Journal of urology.

[52]  H. Ochman,et al.  Standard reference strains of Escherichia coli from natural populations , 1984, Journal of bacteriology.

[53]  W. Anthony,et al.  A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli. , 1983, Reviews of infectious diseases.

[54]  W. Anthony,et al.  A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. , 1982, The Journal of infectious diseases.